CHARLES TOWN, W.Va., Jan. 8 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. , announces new R&D facility.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
“We have leased, fitted and established the infrastructure for a new offsite engineering laboratory that will allow us to streamline the process of new product development. This state of the art R&D facility will house both electronic and pharmaceutical laboratories,” announced David B. Phillips, Ph.D., CEO of RBRM.
“We have the ability to introduce new products into the market via the web and support the sales of new products through our established customer service department. We will be able to fast-track both electronic and pharmaceutical projects; each new project has the potential to double our current revenues. Our current projections give a release date for new products in the third quarter of 2008,” according to Daena Carter, CFO of RBRM.
For more information visit: www.rebuildermedical.com, www.molluscum.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
CONTACT: Daena Carter of ReBuilder Medical Technologies, Inc.,
+1-304-725-2202
Web site: http://www.molluscum.com/
http://www.rebuildermedical.com/
